| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.005 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.006 |
| mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.006 |
| mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.006 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
| mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.006 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.006 |
| mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.006 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.006 |